ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,105.00
-25.00 (-1.17%)
At close: Oct 16, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 56.73 billion as of October 16, 2026. It is the 31,386th most valuable company in the world and the 1,703rd biggest in South Korea. Its market cap has increased by 40.51% in one year.
Market Cap
56.73B
Enterprise Value
54.94B
Revenue
12.57B
Global Rank
Country Rank
#1,703 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 56.73B, an increase of 123.83%. That is a compound annual growth rate of 12.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 56.73B | 70.82% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CTCBIO | 67.54B |
| Naturalendo Tech | 66.94B |
| SunBio,Inc. | 66.57B |
| PanGen Biotech | 64.46B |
| ABION | 60.91B |
| IMGT Co.,Ltd. | 57.66B |
| Psomagen | 56.36B |
| NovMetaPharma | 53.10B |